Postgenomic biotechnologies
The pharmaceutical industry development program assumes that about 200 domestic medicines should be created by 2020. Several dozen of them should be innovative means of a new generation. The creation of such drugs is the main task of the Department of Postgenomic Biotechnologies of the Institute of General Genetics of the Russian Academy of Sciences.
28.10.2008